摘要
目的探讨防己诺林碱对去卵巢小鼠骨质疏松的保护作用。方法将40只C57BL/6小鼠随机分为空白(假手术)对照组、模型(去卵巢)组、阳性(雌二醇,E2)对照组、防己诺林碱组共4组,每组10只。连续腹腔给药7周后处死小鼠,取股骨及外周血清,通过ELISA法检测骨代谢相关血清学指标:抗酒石酸酸性磷酸酶(TRAcP)、I型胶原羧基末端肽(CTX)及I型胶原氨基末端肽(NTX);通过Micro-CT评估各组小鼠骨组织微结构相关指标:骨小梁百分比(BV/TV)、骨小梁数量(Tb.N)、骨小梁分离度(Tb.Sp)和骨小梁厚度(Tb.Th);通过实时荧光定量PCR检测小鼠骨质疏松骨吸收相关基因的表达情况,包括TRAcP、组织蛋白酶K(Cathepsin K)、活化T细胞核因子1(NFATc1)以及降钙素受体(CTR)。结果与去卵巢模型组比较,防己诺林碱治疗组小鼠BV/TV、Tb.N、Tb.Th显著升高,Tb.Sp明显降低,骨代谢相关指标(TRAcP、CTX、NTX)显著降低,破骨细胞标志基因(TRAcP、Cathepsin K、NFATc1以及CTR)表达水平明显下降。结论防己诺林碱对去卵巢小鼠骨质疏松有保护作用,有望为骨质疏松的临床用药提供新思路。
Objective To investigate the protective effect of fangchinoline on ovariectomy-induced osteoporosis.Methods Forty C57BL/6 mice were randomly divided into 4 groups,including blank control(sham)group,ovariectomized(OVX)mice model group,E2-treated group,and fangchinoline-treated group.Each group contained 10 mice.After 7 weeks of abdominal administration,all the mice were sacrificed.Serum was collected for detecting the following osteoporosis related biomarkers:tartrate-resistant acid phosphatase(TRAcP),C-terminal peptide of type I collagen(CTX),and N-terminal telopeptide of type I collagen(NTX).Femurs were removed for micro-CT analysis of the following bone mass index:bone volume/tissue volume(BV/TV),trabecular number(Tb.N),trabecular separation(Tb.Sp),and trabecular thickness(Tb.Th).Real-time PCR was applied to detect the expression of osteoporosis specific genes in femurs,including TRAcP,Cathepsin K,nuclear factor of activated T cells cytoplasmic 1(NFATc1),and calcitonin receptor(CTR).Results Compared with OVX mice model,fangchinoline-treated group had increased levels of BV/TV,Tb.N,and Tb.Th,and decreased level of Tb.Sp.Also,decreased levels of bone resorption related biomarkers,including TRAcP,CTX,and NTX,were found in fangchinoline-treated group.In addition,real-time PCR result showed that fangchinoline-treated group had decreased levels of osteoclast marker genes including TRAcP,Cathepsin K,NFATc1,and CTR.Conclusion Fangchinoline protects against osteoporosis in OVX mice and might provide new ideas for the clinical treatment of osteoporosis.
作者
周琳
杨明理
王博浯
赵毅
曾春平
ZHOU Lin;YANG Mingli;WANG Bowu;ZHAO Yi;ZENG Chunping(Department of Endocrinology, the Fifth Guangzhou Medical University, the Fifth Clinical School of Guangzhou Medical University, Guangzhou 510700;Department of Medical Genetics, Zunyi Medical University, Zunyi 563000, China)
出处
《中国骨质疏松杂志》
CAS
CSCD
北大核心
2020年第11期1609-1612,1663,共5页
Chinese Journal of Osteoporosis
基金
遵义医学院博士启动基金(F-871)
遵义市科技计划项目(遵市科合HZ字202036号)
遵义医学院与科技学院大学生创新创业训练计划项目(遵医科院20173810,遵医科院20173831)
贵州省大学生创新创业训练计划项目(2018521443)
广东省教育厅青年创新人才类项目(2017KQNCX167)
广东省医学科研基金(A2019006)
2019年度广东省基础与应用基础研究基金联合基金青年基金项目(2019A1515110723)。
关键词
防己诺林碱
去卵巢小鼠
骨质疏松
骨代谢
fangchinoline
ovariectomized mice
osteoporosis
bone metabolism